Latigo Biotherapeutics, Inc. LTGO
14.68 USD +1.17 (+8.62%)
Nov 3, 2026, 3:28 PM EST
13.53 Day range 15.10
13.26 52-week range 25.93
- YTD
- -19.59%
- 1 year
- -19.59%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 52.25 +256.0% upside
Now 14.68
- Target (low)
- 36.00
- Target (mean)
- 52.25
- Target (high)
- 73.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy0
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.67 | -0.69 – -0.65 | 0.00 | 0.0% | 0 | 0.0% | 2 |
| Next quarter | -0.85 | -0.86 – -0.84 | 0.00 | 0.0% | 0 | 0.0% | 2 |
| Current year | -3.01 | -4.52 – -2.11 | -129.26 | +97.7% | 0 | 0.0% | 3 |
| Next year | -2.32 | -2.76 – -2.07 | -3.01 | +23.0% | 0 | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 1, 2026 | Leerink Partners | Initiated | — | Outperform |
| Sep 1, 2026 | Jefferies | Initiated | — | Buy |
| Sep 1, 2026 | Guggenheim | Initiated | — | Buy |